High prevalence of risk factors for physical illness in a long-stay psychiatric unit

Irish Journal of Psychological Medicine

Volumn 24, Issue 2, 2007, Pages 55-58

  O'Brien, Sinead ^a   Devitt, Enda ^b   Ahmed, Mohamed ^c   McDonald, Colm ^d  

^a St Anne's Day Hospital   (Ireland)

^b Western Area GP Training Scheme   (Sierra Leone)

^c St Brigid's Hospital   (Ireland)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Long stay; Metabolic syndrome; Physical illness

Indexed keywords

CHOLESTEROL; ELECTROLYTE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROLACTIN; TRIACYLGLYCEROL; UREA;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC PATIENT; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER FUNCTION TEST; LONG TERM CARE; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL DISEASE; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY MEDICAL CARE; PSYCHIATRIC DEPARTMENT; RISK FACTOR; THYROID FUNCTION TEST;

EID: 34548794966     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700010223     Document Type: Article

References (23)

1. Barraclough EC, Harris B. Excess mortality of mental disorder. Br J Psychiatry 1998; 173: 11-53.
2. Cormac I, Martin D, Ferriter M. Improving the physical health of long-stay psychiatric patients. Adv Psychiatr Treat 2004; 10: 107-15.
3. Brown S, Barraclough B, Inskip H. Cause of the excess mortality in schizophrenia. Br J Psychiatry 2000; 177: 212-7.
4. Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can. J Psychiatry 1991; 36: 239-45.
5. Dinan TG. The physical consequences of depressive illness. BMJ 1999; 318: 826.
6. Van Schrojenstein Lantman-De Valk HMJ, Metsemakers JFM, Haveman JM. Health problems in people with intellectual disability in general practice: a comparative study. Fam Pract 2000; 17: 405-7.
7. Marder SR et al. Physical health monitoring with schizophrenia. Am J Psychiatry 2004; 161: 1334-49.
8. Jeste DV, Gladsjo J, Lindamar LA, Lacro JP. Medical comorbidity in schizophrenia. Schizophr Bull 1996;22: 413-20.
9. Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county Sweden. Schizophr Res 2000; 45: 21-8.
10. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-217.
11. Penninx BW et al. Depression and cardiac mortality: results from a community based longitudinal study. Arch Gen Psychiatry 2001; 58: 221-7.
12. McEvoy JP et al. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005; 80:19-32.
13. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES); National Cholesterol Education Programme (NCEP). NCEP defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-4.
14. Expert Panel on Detection and Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
15. Villegas R, Perry IJ, Creagh D, Hinchion R, O'Halloran D. Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care 2003; 26: 3198-9.
16. Mehta SK, Holliday C, Hayuk L. Effect of regular exercise after third decade on doppler derived left ventricular filling. Am J Cardiol 2004; 94; 1595-7.
17. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64: 663-7.
18. Basu R, Chengappa KN, John V. The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar type. Bipolar Disord 2004; 6:314-8.
19. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
20. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Thorax 2000; 55: 987-9.
21. Homel P, Casey D, Allison D. Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophr Res 2002; 55: 277-84.
22. Meaney AM, Smith S, Howes OD, O'Brien OD, Murray RM, O'Keane V. Br J Psychiatry 2004; 184: 503-508.
23. Ness G. The limited value of the annual physical health examination in long-term secure care. Psychiatric Bull 2001; 25: 154-5.